Droga5 Names David Kolbusz Chief Creative Officer of London Office

News Follows Announcement of His Departure from Wieden & Kennedy New York

By Published on .

David Kolbusz, CCO Droga5 London
David Kolbusz, CCO Droga5 London

Following Wieden & Kennedy New York's announcement yesterday that its top creatives, ECDs David Kolbusz and Jaime Robinson would be leaving, Droga5 has announced that Mr. Kolbusz has been named chief creative officer of Droga 5 London.

The move marks a return to London for Mr. Kolbusz, who officially starts in November. Before he joined Wieden in 2014, the Canadian native was deputy ECD and partner at BBH London, where he oversaw award-winning campaigns such as The Guardian's "Three Little Pigs," as well as Axe/Unilever's "Peace" and "Apollo" campaigns.

Prior to BBH, he worked at other top shops including Goodby, Silverstein & Partners and Mother. Mr. Kolbusz' arrival follows the recent appointment of Bill Scott to CEO, from his post as managing director at Grey London.

Mr. Kolbusz' appointment may be a good turn for the agency, which has struggled globally at its outposts in London and Australia. The U.K. office saw the departures of CEO Kevin Dundas in 2014 and that of CCO Nik Studzinski this year, while the agency shuttered its office in Sydney last month, following the departure of ECD Steve Coll.

David Droga, creative chairman and founder of Droga5, said in a statement, "David has proven himself over and over to be truly one of the world's best creative leaders. In fact, I have been trying to find a way to work with David for years, and now, with both David and Bill, I couldn't be more excited about our future in London and beyond."

"London is my spiritual home," added Mr. Kolbusz. "The opportunity to head back and work with Bill to build up the Droga5 brand in the UK market proved impossible to pass up. David, Sarah (Thompson) and everyone I've met from the agency family so far all have big brains and even bigger hearts. I'm excited for the future and to see what we can do together."

Most Popular